Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2007

01-09-2007 | Original Article

Racial and Socioeconomic Disparities in Bone Density Testing Before and After Hip Fracture

Authors: Joan M. Neuner, MD, MPH, Xu Zhang, PhD, Rodney Sparapani, MS, Purushottam W. Laud, PhD, Ann B. Nattinger, MD, MPH

Published in: Journal of General Internal Medicine | Issue 9/2007

Login to get access

Abstract

BACKGROUND

Racial and socioeconomic disparities have been identified in osteoporosis screening.

OBJECTIVE

To determine whether racial and socioeconomic disparities in osteoporosis screening diminish after hip fracture.

DESIGN

Retrospective cohort study of female Medicare patients.

SETTING

Entire states of Illinois, New York, and Florida.

PARTICIPANTS

Female Medicare recipients aged 65–89 years old with hip fractures between January 2001 and June 2003.

MEASUREMENTS

Differences in bone density testing by race/ethnicity and zip-code level socioeconomic characteristics during the 2-year period preceding and the 6-month period following a hip fracture.

RESULTS

Among all 35,681 women with hip fractures, 20.7% underwent bone mineral density testing in the 2 years prior to fracture and another 6.2% underwent testing in the 6 months after fracture. In a logistic regression model adjusted for age, state, and comorbidity, women of black race were about half as likely (RR 0.52 [0.43, 0.62]) and Hispanic women about 2/3 as likely (RR 0.66 [0.54, 0.80]) as white women to undergo testing before their fracture. They remained less likely (RR 0.66 [0.50, 0.88] and 0.58 [0.39, 0.87], respectively) to undergo testing after fracture. In contrast, women residing in zip codes in the lowest tertile of income and education were less likely than those in higher-income and educational tertiles to undergo testing before fracture, but were no less likely to undergo testing in the 6 months after fracture.

CONCLUSIONS

Racial, but not socioeconomic, differences in osteoporosis evaluation continued to occur even after Medicare patients had demonstrated their propensity to fracture. Future interventions may need to target racial/ethnic and socioeconomic disparities differently.
Appendix
Available only for authorised users
Literature
1.
go back to reference Neuner JM, Binkley N, Sparapani RA, Laud PW, Nattinger AB. Bone density testing in older women and its association with patient age. J Am Geriatr Soc. 2006;54(3):485–9.PubMedCrossRef Neuner JM, Binkley N, Sparapani RA, Laud PW, Nattinger AB. Bone density testing in older women and its association with patient age. J Am Geriatr Soc. 2006;54(3):485–9.PubMedCrossRef
2.
go back to reference Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med. 2004;117(12):919–24.PubMedCrossRef Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med. 2004;117(12):919–24.PubMedCrossRef
3.
go back to reference Miller RG, Ashar BH, Cohen J, et al. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005;20(9):847–51.PubMedCrossRef Miller RG, Ashar BH, Cohen J, et al. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005;20(9):847–51.PubMedCrossRef
4.
go back to reference Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: The National Academies Press; 2002. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: The National Academies Press; 2002.
5.
go back to reference Cauley JA, Lui L-Y, Ensrud KE, et al. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA. 2005;293(17):2102–8.PubMedCrossRef Cauley JA, Lui L-Y, Ensrud KE, et al. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA. 2005;293(17):2102–8.PubMedCrossRef
6.
go back to reference Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–94.CrossRef Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–94.CrossRef
7.
go back to reference Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280(24):2077–82.PubMedCrossRef Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280(24):2077–82.PubMedCrossRef
8.
go back to reference Harris S, Watts N, Genant H, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344–52.PubMedCrossRef Harris S, Watts N, Genant H, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344–52.PubMedCrossRef
9.
go back to reference Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333(22):1437–43.PubMedCrossRef Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333(22):1437–43.PubMedCrossRef
10.
go back to reference Colon-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int. 2003;14(11):879.PubMedCrossRef Colon-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int. 2003;14(11):879.PubMedCrossRef
11.
go back to reference U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004. U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004.
12.
go back to reference Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract. 2001;7(4):293–312.PubMed Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract. 2001;7(4):293–312.PubMed
13.
go back to reference National Osteoporosis Foundation. Physicians’ Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 1999. National Osteoporosis Foundation. Physicians’ Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 1999.
14.
go back to reference NIH. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online March 27–29 2000. (Accessed 2006 November 21); 17(1):1–36. NIH. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online March 27–29 2000. (Accessed 2006 November 21); 17(1):1–36.
16.
go back to reference Ray WA, Griffin MR, Fought RL, Adams ML. Identification of fractures from computerized Medicare files. J Clin Epidemiol. 1992;45(7):703–14.PubMedCrossRef Ray WA, Griffin MR, Fought RL, Adams ML. Identification of fractures from computerized Medicare files. J Clin Epidemiol. 1992;45(7):703–14.PubMedCrossRef
17.
go back to reference U.S. Department of Health and Human Services. Health Technology Assessment. Number 6: Bone Densitometry: Patients with Asymtomatic Hyperparathyroidism. AHRQ Publication No. 96-0004. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; 1995. U.S. Department of Health and Human Services. Health Technology Assessment. Number 6: Bone Densitometry: Patients with Asymtomatic Hyperparathyroidism. AHRQ Publication No. 96-0004. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; 1995.
18.
go back to reference Bates DW, Black DM, Cummings SR. Clinical use of bone densitometry: clinical applications. JAMA. 2002;288(15):1898–900.PubMedCrossRef Bates DW, Black DM, Cummings SR. Clinical use of bone densitometry: clinical applications. JAMA. 2002;288(15):1898–900.PubMedCrossRef
19.
go back to reference Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003;115(5):398–400.PubMedCrossRef Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003;115(5):398–400.PubMedCrossRef
20.
go back to reference Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–10.PubMed Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–10.PubMed
21.
go back to reference Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148(5):475–86.PubMed Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148(5):475–86.PubMed
22.
go back to reference Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef
23.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.PubMedCrossRef Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.PubMedCrossRef
24.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.PubMedCrossRef
25.
go back to reference Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef
26.
go back to reference Mudano AS, Casebeer L, Patino F, et al. Racial disparities in osteoporosis prevention in a managed care population. South Med J. 2003;96(5):445–51.PubMedCrossRef Mudano AS, Casebeer L, Patino F, et al. Racial disparities in osteoporosis prevention in a managed care population. South Med J. 2003;96(5):445–51.PubMedCrossRef
27.
go back to reference Wilkins CH, Goldfeder JS. Osteoporosis screening is unjustifiably low in older African-American women. J Natl Med Assoc. 2004;96(4):461–7.PubMed Wilkins CH, Goldfeder JS. Osteoporosis screening is unjustifiably low in older African-American women. J Natl Med Assoc. 2004;96(4):461–7.PubMed
28.
go back to reference Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm A. Race and sex differences in mortality following fracture of the hip. Am J Public Health. 1992;82(8):1147–50.PubMedCrossRef Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm A. Race and sex differences in mortality following fracture of the hip. Am J Public Health. 1992;82(8):1147–50.PubMedCrossRef
29.
go back to reference Furstenberg A, Mezey M. Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis. 1987;40(10):931–8.PubMedCrossRef Furstenberg A, Mezey M. Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis. 1987;40(10):931–8.PubMedCrossRef
30.
go back to reference Burgess DJ, Fu SS, van Ryn M. Why do providers contribute to disparities and what can be done about it? J Gen Intern Med. 2004;19(11):1154–9.PubMedCrossRef Burgess DJ, Fu SS, van Ryn M. Why do providers contribute to disparities and what can be done about it? J Gen Intern Med. 2004;19(11):1154–9.PubMedCrossRef
31.
go back to reference Balsa AI, McGuire TG. Prejudice, clinical uncertainty and stereotyping as sources of health disparities. J Health Econ. 2003;22(1):89–116.PubMedCrossRef Balsa AI, McGuire TG. Prejudice, clinical uncertainty and stereotyping as sources of health disparities. J Health Econ. 2003;22(1):89–116.PubMedCrossRef
32.
go back to reference Pathman D, Fowler-Brown A, Corbie-Smith G. Differences in access to outpatient medical care for black and white adults in the Rural South. Med Care. 2006;44(5):429–38.PubMedCrossRef Pathman D, Fowler-Brown A, Corbie-Smith G. Differences in access to outpatient medical care for black and white adults in the Rural South. Med Care. 2006;44(5):429–38.PubMedCrossRef
33.
go back to reference U.S. Congress Office of Technology Assessment. Hip Fracture Outcomes in People Age 50 and Over—Background Paper. OTA-BP-H-120. Washington, DC: U.S. Government Printing Office; 1994. U.S. Congress Office of Technology Assessment. Hip Fracture Outcomes in People Age 50 and Over—Background Paper. OTA-BP-H-120. Washington, DC: U.S. Government Printing Office; 1994.
34.
go back to reference Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for hip fracture in black women. N Engl J Med. 1994;330(22):1555–9.PubMedCrossRef Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for hip fracture in black women. N Engl J Med. 1994;330(22):1555–9.PubMedCrossRef
35.
go back to reference Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–94.PubMedCrossRef Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–94.PubMedCrossRef
36.
go back to reference Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879–88.PubMedCrossRef Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879–88.PubMedCrossRef
37.
38.
go back to reference Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–7.PubMed Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–7.PubMed
39.
go back to reference Harrington JT, Barash HL, Day S, Lease J. Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum. 2005;53(2):198–204.PubMedCrossRef Harrington JT, Barash HL, Day S, Lease J. Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum. 2005;53(2):198–204.PubMedCrossRef
Metadata
Title
Racial and Socioeconomic Disparities in Bone Density Testing Before and After Hip Fracture
Authors
Joan M. Neuner, MD, MPH
Xu Zhang, PhD
Rodney Sparapani, MS
Purushottam W. Laud, PhD
Ann B. Nattinger, MD, MPH
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0217-1

Other articles of this Issue 9/2007

Journal of General Internal Medicine 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.